Tabla 4.
Tipo de fármaco | Insulinas | ADO secretagogos | ADO no secretagogos | Control metabólico (%HbA1c) |
|||
---|---|---|---|---|---|---|---|
Bueno (< 7%) | Aceptable (7-8%) | Malo (>8%) | Desconocido | ||||
No antidiabético | No | No | No | 521 (71%) | 62 (9%) | 16 (2%) | 130 (18%) |
ADO no secretagogo | No | No | Sí | 1.079 (61%) | 378 (21%) | 119 (7%) | 187 (11%) |
ADO secretagogo | No | Sí | No | 186 (58%) | 72 (22%) | 23 (7%) | 41 (13%) |
Sí | 355 (37%) | 299 (31%) | 217 (23%) | 90 (9%) | |||
Insulina | Sí | No | No | 98 (22%) | 106 (24%) | 140 (32%) | 93 (21%) |
Sí | 136 (26%) | 153 (29%) | 189 (36%) | 52 (10%) | |||
Sí | No | 14 (26%) | 16 (30%) | 19 (36%) | 4 (8%) | ||
Sí | 39 (21%) | 56 (29%) | 84 (44%) | 11 (6%) | |||
Total | 2.428 (49%) | 1.142 (23%) | 807 (16%) | 608 (12%) |
ADO: antidiabéticos orales; SSIBE: población asignada a Serveis de Salut integrats Baix Empordà.